<DOC>
	<DOCNO>NCT00346424</DOCNO>
	<brief_summary>The purpose study compare safety effectiveness alfimeprase placebo restore function occlude central catheter .</brief_summary>
	<brief_title>Safety Efficacy Study Alfimeprase Subjects With Occluded Central Catheters</brief_title>
	<detailed_description>Primary Outcomes : The ability withdraw least 3 ml blood infuse least 5 mL sterile saline occlude catheter lumen 15 minute receive initial instillation study drug . Secondary Outcomes : The ability withdraw least 3 mL blood infuse least 5 mL sterile saline occlude catheter lumen 30 minute follow single instillation study drug 30 minute follow second instillation study drug patency restore within 30 minute first instillation . Safety : - Adverse event - Major bleed event - Change laboratory value .</detailed_description>
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Venous Thrombosis</mesh_term>
	<criteria>Must give write informed consent Unable withdraw 3 mL blood central venous access device Hemodynamically stable Available followup assessment Inability infuse least 2 mL saline catheter Catheter place less 48 hour prior detection occlusion Catheter use hemodialysis pheresis Less 18 year age Evidence mechanical nonthrombotic occlusion Receipt thrombolytic agent within 24 hour randomization In opinion investigator , subject `` high risk '' bleed event embolic complication , condition bleed constitutes significant hazard Increased risk drug extravasation Pregnant , lactating , actively menstruate woman woman childbearing potential use adequate contraceptive precaution ( e.g . intrauterine device , oral contraceptive , barrier method , contraception deem adequate investigator ) Known righttoleft cardiac shunt , patent foramen ovale , atrial/ventricular septal defect Participation study investigational device , medication , biologic , agent within 30 day enrollment 30day follow visit Any subject feature opinion investigator preclude study participation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2008</verification_date>
	<keyword>occluded central catheter</keyword>
	<keyword>central venous access device dysfunction</keyword>
	<keyword>withdrawal occlusion</keyword>
	<keyword>Thrombosis</keyword>
	<keyword>Venous thrombosis</keyword>
</DOC>